NKTX
Nkarta Inc

2,167
Loading...
Loading...
News
all
press releases
Nkarta (NKTX) Moves to Buy: Rationale Behind the Upgrade
Zacks·4mo ago
News Placeholder
More News
News Placeholder
Buy Rating Confirmed: Expanding Potential of Nkarta's NKX019 in SLE Treatment
Analyst Emily Bodnar from H.C. Wainwright maintained a Buy rating on Nkarta (NKTX Research Report) and keeping the price target at $23.00. Emily...
TipRanks Financial Blog·1y ago
News Placeholder
Nkarta Announces New President and Strategic Executive Shifts
The latest announcement is out from Nkarta (NKTX). Nkarta, Inc. has appointed Nadir Mahmood, Ph.D., previously CEO of Rezo Therapeutics, as its new...
TipRanks Financial Blog·1y ago
News Placeholder
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
Glancy Prongay & Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Nkarta, Inc. (Nkarta or the Company) (NASDAQ...
Business Wire·1y ago
News Placeholder
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Nkarta, Inc. (Nkarta or the Company) (NASDAQ: NKTX) investors concerning the Companys possible violations of federal securities...
Business Wire·1y ago
News Placeholder
The Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Nkarta, Inc. (Nkarta or the Company) (NASDAQ: NKTX) on behalf of investors concerning the Companys possible violations of federal...
Business Wire·1y ago
News Placeholder
Nkarta to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced...
Globe Newswire·1y ago
News Placeholder
Nkarta (NASDAQ:NKTX) Stock Price Down 5.7%
Nkarta, Inc. (NASDAQ:NKTX - Get Free Report)'s share price fell 5.7% on Tuesday . The company traded as low as $10.11 and last traded at $10.20. 68,322 shares were traded during mid-day trading, a...
Ticker Report·1y ago
News Placeholder
Huge Insider Buying From Buffett, an NFL Team Owner, a New CEO
Yet again, the Oracle of Omaha has bolstered his stake in a media giant's tracking stocks. However, Warren Buffett was not the only one making notable insider purchases in the past week or so. An NFL...
24/7 Wall St.·1y ago
News Placeholder
Nkarta, Inc. (NASDAQ:NKTX) Director Simeon George Acquires 2,000,000 Shares
Nkarta, Inc. (NASDAQ:NKTX Get Free Report) Director Simeon George purchased 2,000,000 shares of Nkarta stock in a transaction that occurred on Wednesday, March 27th. The shares were acquired...
Ticker Report·1y ago

Latest NKTX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.